The low and disproportionate utilization of antiresorptive therapy in patients with osseous metastasis

INTRODUCTION: Antiresorptive therapies are commonly utilized to mitigate and prevent skeletal-related-events in patients with metastatic osseous disease. However, limited data exists on the incidence or factors associated with prescription of antiresorptives or their effects on the incidence of path...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Amil R., LiBrizzi, Christa L., Wessel, Lauren, Thakkar, Savyasachi C., Levin, Adam S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585374/
https://www.ncbi.nlm.nih.gov/pubmed/37868617
http://dx.doi.org/10.1016/j.jbo.2023.100507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585374/
https://www.ncbi.nlm.nih.gov/pubmed/37868617
http://dx.doi.org/10.1016/j.jbo.2023.100507

Ejemplares similares